Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours.
Pico JL, Rosti G, Kramar A, Wandt H, Koza V, Salvioni R, Theodore C, Lelli G, Siegert W, Horwich A, Marangolo M, Linkesch W, Pizzocaro G, Schmoll HJ, Bouzy J, Droz JP, Biron P; Genito-Urinary Group of the French Federation of Cancer Centers (GETUG-FNCLCC), France; European Group for Blood and Marrow Transplantation (EBMT). Pico JL, et al. Among authors: linkesch w. Ann Oncol. 2005 Jul;16(7):1152-9. doi: 10.1093/annonc/mdi228. Epub 2005 May 31. Ann Oncol. 2005. PMID: 15928070 Free article. Clinical Trial.
(90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial.
Scholz CW, Pinto A, Linkesch W, Lindén O, Viardot A, Keller U, Hess G, Lastoria S, Lerch K, Frigeri F, Arcamone M, Stroux A, Frericks B, Pott C, Pezzutto A. Scholz CW, et al. Among authors: linkesch w. J Clin Oncol. 2013 Jan 20;31(3):308-13. doi: 10.1200/JCO.2011.41.1553. Epub 2012 Dec 10. J Clin Oncol. 2013. PMID: 23233718 Clinical Trial.
CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trial.
Fridrik MA, Hausmaninger H, Linkesch W, Stöger M, Sill H, Neubauer M, Seewann HL, Klocker J, Haidinger R, Schiller L, Pont J, Raudaschl G, Falk M, Radaszkiewicz T. Fridrik MA, et al. Among authors: linkesch w. J Clin Oncol. 1996 Jan;14(1):227-32. doi: 10.1200/JCO.1996.14.1.227. J Clin Oncol. 1996. PMID: 8558202 Clinical Trial.
Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study.
Jäger G, Neumeister P, Brezinschek R, Hinterleitner T, Fiebiger W, Penz M, Neumann HJ, Mlineritsch B, DeSantis M, Quehenberger F, Chott A, Beham-Schmid C, Höfler G, Linkesch W, Raderer M. Jäger G, et al. Among authors: linkesch w. J Clin Oncol. 2002 Sep 15;20(18):3872-7. doi: 10.1200/JCO.2002.05.117. J Clin Oncol. 2002. PMID: 12228207 Clinical Trial.
Paclitaxel-containing high-dose chemotherapy in high-risk breast cancer patients.
Greinix HT, Linkesch W, Seifert M, Kubista E, Czerwenka K, Elahi F, Zielinski C, Hoecker P, Steger G, Schulenburg A, Neumeister G, Rabitsch W, Jakesz R, Kalhs P. Greinix HT, et al. Among authors: linkesch w. Acta Oncol. 2000;39(1):47-52. doi: 10.1080/028418600430969. Acta Oncol. 2000. PMID: 10752653 Clinical Trial.
Long-term results of dose density therapy in patients with aggressive lymphoma.
Fridrik MA, Hausmaninger H, Linkesch W, Greil R, Krieger O, Baldinger C, Klocker J, Pont J, Oberaigner W. Fridrik MA, et al. Among authors: linkesch w. Ann Hematol. 2005 Apr;84(4):217-22. doi: 10.1007/s00277-004-0936-x. Epub 2004 Nov 6. Ann Hematol. 2005. PMID: 15538568 Clinical Trial.
R-CHOP versus R-COMP: are they really equally effective?
Mian M, Wasle I, Gamerith G, Mondello P, Melchardt T, Jäger T, Linkesch W, Fiegl M. Mian M, et al. Among authors: linkesch w. Clin Oncol (R Coll Radiol). 2014 Oct;26(10):648-52. doi: 10.1016/j.clon.2014.05.012. Epub 2014 Jun 12. Clin Oncol (R Coll Radiol). 2014. PMID: 24929649
224 results